Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Omeprazole

Omeprazole

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Omeprazole

54 trials tracked of Omeprazole: 19 in phase 3 or 4 and 2 with published results. The most-cited published study has 17 citations.

54Trials tracked
19Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 12 Phase 3 7 Phase 2 4 Phase 1 26 Other / NA 5
  1. Phase 4 Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial Completed · 17 cited
  2. Phase 4 Placebo In Chronic Back Pain (Phase 2) Completed · 16 cited
  3. Phase 4 High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population Completed
  4. Phase 4 Ranitidin Versus Omeprazole in Patients Taking Clopidogrel Completed
  5. Phase 4 The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease Completed
  6. Phase 4 Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Completed
Show 44 more trials
  1. Phase 4 Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers Completed
  2. Phase 4 Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout Completed
  3. Phase 4 Does Omeprazole Decrease Intestinal Calcium Absorption? Completed
  4. Phase 4 Gastric Acid Suppression and Probiotic Colonization Completed
  5. Phase 4 Ulcer Prevention Study in Post Gastric Bypass Patients Completed
  6. Phase 4 Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? Completed
  7. Phase 3 Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea Completed
  8. Phase 3 A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients Completed
  9. Phase 3 Reflux Esophagitis Phase III Study (Initial Treatment) Completed
  10. Phase 3 A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED) Completed
  11. Phase 3 A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED) Completed
  12. Phase 3 An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis Completed
  13. Phase 3 Reflux Esophagitis Phase III Study (Maintenance Treatment) Completed
  14. Phase 2 Oral OKT3 for the Treatment of Active Ulcerative Colitis Completed
  15. Phase 2 IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity Completed
  16. Phase 2 Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy Completed
  17. Phase 2 A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer Completed
  18. Phase 1 A Study of Baricitinib and Omeprazole in Healthy Participants Completed
  19. Phase 1 A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants Completed
  20. Phase 1 Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors Completed
  21. Phase 1 A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults Completed
  22. Phase 1 Effect of a Proton Pump Inhibitor on the PK of Tepotinib Completed
  23. Phase 1 Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) Completed
  24. Phase 1 Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4 Completed
  25. Phase 1 Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin Completed
  26. Phase 1 A Study of LY3484356 in Healthy Female Participants Completed
  27. Phase 1 Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients Completed
  28. Phase 1 Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir Completed
  29. Phase 1 A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults Completed
  30. Phase 1 Voxelotor CYP and Transporter Cocktail Interaction Study Completed
  31. Phase 1 A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers Completed
  32. Phase 1 Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers Completed
  33. Phase 1 A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants Completed
  34. Phase 1 A Study of Imlunestrant (LY3484356) in Female Healthy Participants Completed
  35. Phase 1 A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005) Completed
  36. Phase 1 A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body Completed
  37. Phase 1 Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy Participants Completed
  38. Phase 1 A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants Completed
  39. Phase 1 GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects Completed
  40. Phase 1 Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants Completed
  41. Phase 1 A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) Completed
  42. Phase 1 Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers Completed
  43. Phase 1 Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants Completed
  44. N/A Proton Pump Inhibitors and Dysbiosis in Cirrhosis Completed

Showing the 50 most-cited and recently-updated of 54 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.